Generics 8

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Phytonadione manufacturers

8 products found

Filters

8 products found

phytonadione

Solution for injection 10mg/1ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
South Korea
GMP approvals
South Korea
Manufacturer #8104
It was established in the late 1950s. It has been making significant efforts to protect the healthy lives of human beings by producing a variety of treatments starting with injection Products. The company operates its business for various customers including business clients, patients, pharmacists, and doctors. They are trying to make their supply chain more effective to provide the necessary medicines faster.

Manufacturer usually replies in 4 days

phytonadione

Injection, pre-filled syringe 1 mg/ml - 0.5 ml

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA, TGA, WHO
Manufacturer #12792
This company focuses on nurturing healthy living through a range of pharmaceutical products aiding in disease treatment and prevention. They offer branded formulations, specialty generics, injectables, vaccines, and biologics across various therapy areas. Key product lines include prescription medications, over-the-counter drugs, and vaccines targeting diseases like Hepatitis B, Covid-19, Diphtheria, Tetanus, Pertussis, and Japanese Encephalitis. Principal dosage forms include injections and oral formulations. The company operates in regions like the EU and North America, adhering to strict GMP certifications for quality assurance. They also hold patents for specific products, highlighting their commitment to innovation.

Manufacturer usually replies in 6 days

phytonadione

Vials, injection 10 mg/ml - 1 ml

Dossier type
US CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA
Comments
ANDA / R &D Status: ANDA to be filed in Q2-2023, approval expected Q2-2024; US RLD / Holder: Vitamin K1 / Hospira ; Indication: Vitamin K dietary supplement;
Manufacturer #8216
This fast-growing pharmaceutical company boasts a dominant presence in Latin America, Francophone Africa, and a growing footprint in regulated markets like the EU and North America. Founded in 1990, it initially focused on ointments and creams before expanding its product range significantly. With over 4,000 global product licenses, they cater primarily to the "Bottom of the Pyramid" through their owned distribution networks. The company's manufacturing facility holds multiple certifications including US FDA approval (with three successful inspections since 2016), EU-GMP, ANVISA-Brazil, INVIMA-Colombia, and COFEPRIS-Mexico. They prioritize innovation with a significant portion of their earnings invested in research and development of safe and effective products across various dosage forms. Key therapy areas are not specified.

Manufacturer usually replies in 6 days

Want to see all 8 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation